Tango Therapeutics, Inc. (TNGX) is a publicly traded Healthcare sector company. As of November 9, 2026, TNGX trades at $21.83 with a market cap of $3.63B and a P/E ratio of -26.13. TNGX moved +1.53% today. Year to date, TNGX is +140.76%; over the trailing twelve months it is +168.41%. Its 52-week range spans $1.03 to $34.39. Analyst consensus is strong buy with an average price target of $44.14. Rallies surfaces TNGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
8 analysts cover TNGX: 0 strong buy, 7 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $44.14.
| Metric | Value |
|---|---|
| Price | $21.83 |
| Market Cap | $3.63B |
| P/E Ratio | -26.13 |
| EPS | $-0.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $34.39 |
| 52-Week Low | $1.03 |
| Volume | 31.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $53.81M |
| Net Income | $-123.72M |
| Gross Margin | 0.00% |
8 analysts cover TNGX: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.14.